Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801

Molecular Brain Research

Volumn 35, Issue 1-2, 1996, Pages 183-189

  Svenningsson, Per ^a   Johansson, Björn ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; CAFFEINE; DIZOCILPINE; KYNURENIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; IMMEDIATE EARLY GENE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDE PROBE; ONCOGENE C FOS; PRIORITY JOURNAL; PUTAMEN; RAT;

ANIMALIA;

EID: 0030028490     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00202-4     Document Type: Article

References (53)

1. Ackerman, S.L., Minden, A.G., Williams, G.T., Bobonis, C. and Yeung, C.-Y., Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promotor, Proc. Natl. Acad. Sci. USA, 88 (1991) 7523-7527.
2. Alexander, S.P. and Reddington, M., The cellular localization of adenosine receptors in rat striatum, Neuroscience, 28 (1989) 645-651.
3. Andiné, P., Lehmann, A., Ellrén, K., Wennberg, E., Kjellmer, I., Nielsen, T. and Hagberg, H., The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection, Neurosci. Lett., 90 (1988) 208-212.
4. Bardo, M.T. and Hammer Jr., R.P., Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: resistance to differential rearing conditions, Neuroscience, 45 (1991) 281-290.
5. Berretta, S., Robertson, H.A. and Graybiel, A.M., Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum, J. Neurophysiol., 68 (1992) 767-777.
6. Bresink, I., Danysz, W., Parsons, C.G. and Mutschler, E., Different binding affinities of NMDA receptor channel blockers in vartrious brain regions-indication of NMDA receptor heterogeneity, Neuropharmacology, 34 (1995) 533-540.
7. Chergui, K., Charlety, P.J., Akaoka, H., Saunier, C.F., Brunet, J.L., Buda, M., Svensson, T.H. and Chovet, G., Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo, Eur. J. Neurosci., 5 (1993) 137-144.
8. Couceyro, P., Pollock, K.M., Drews, K. and Douglass, J., Cocaine differentially regulates activator protein-1 mRNA levels and DNA-binding complexes in the rat striatum and cerebellum, Mol. Pharmacol., 46 (1994) 667-676.
9. Daly, J.W., Mechanism of action of caffeine. In: S. Garattini (Ed.), Caffeine, Coffee, and Health, Raven Press, New York, 1993, pp. 97-150.
10. Deutch, A.Y. and Cameron, D.S., Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell, Neuroscience, 46 (1992) 49-56.
11. Donoghue, J.P. and Herkenham, M., Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat, Brain Res., 365 (1986) 397-403.
12. 2 receptor antagonists induce fos and related proteins in rat striatal neurons, Neuroscience, 37 (1990) 287-294.
13. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals, Neuroscience, 22 (1987) 813-826.
14. 2 dopamine receptors in rat striatum, Mol. Brain Res., 14 (1992) 186-195.
15. Fredholm, B.B., Are methylxanthine effects due to antagonism of endogenous adenosine?, Trends Pharmacol. Sci., 1 (1980) 129-132.
16. Fredholm, B.B., Adenosine, adenosine receptors and the actions of caffeine, Pharmacol. Toxicol., 76 (1995) 93-101.
17. Fredholm, B.B. and Dunwiddie, T.V., How does adenosine inhibit transmitter release?, Trends Pharmacol. Sci., 9 (1988) 130-134.
18. Fu, L. and Beckstead, R.M., Cortical stimulation induces fos expression in striatal neurons, Neuroscience, 46 (1992) 329-334.
19. Gass, P., Herdegen, T., Bravo, R. and Kiessling, M., Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801, Neuroscience, 53 (1993) 749-758.
20. 1 receptor number, Brain Res., 612 (1993) 271-277.
21. Gerfen, C.R., The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci., 15 (1992) 133-139.
22. Holtzman, S.G. and Finn, I.B., Tolerance to behavioral effects of caffeine in rats, Pharmacol. Biochem. Behav., 29 (1988) 411-418.
23. Hughes, P. and Dragunow, M., Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system, Pharmacol. Rev., 47 (1995) 133-178.
24. 2 receptor stimulation on electrically evoked dopamine and acetylcholine release from rat striatal slices, J. Pharmacol. Exp. Ther., 267 (1993) 801-808.
25. 2 adenosine receptor binding and on mRNA levels, Naunyn-Schmiedeberg's Arch. Pharmacol., 347 (1993) 407-414.
26. Johansson, B., Lindström, K. and Fredholm, B.B., Differences in the regional and cellular localization of c-fos mRNA induced by amphetamine, cocaine and caffeine in the rat, Neuroscience, 59 (1994) 837-849.
27. Jongen-Relo, A.L., Voorn, P. and Groenewegen, H.J., Immunohistochemical characterization of the shell and core territories of the nucleus accumbens in the rat, Eur. J. Neurosci., 6 (1994) 1255-1264.
28. 1 receptor and is dependent on NMDA stimulation, Mol. Brain Res., 23 (1994) 1-13.
29. Kiss, J.P., Toth, E., Lajtha, A. and Vizi, E.S., NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study, Brain Res., 641 (1994) 145-148.
30. Liu, J., Nickolenko, J. and Sharp, F.R., Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors, Proc. Natl. Acad. Sci. USA, 91 (1994) 8537-8541.
31. Merchant, K.M. and Miller, M.A., Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol, Mol. Brain Res., 23 (1994) 271-277.
32. Milbrandt, J., A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor, Science, 238 (1987) 797-799.
33. Murase, S., Mathe, J.M., Grenhoff, J. and Svensson, T.H., Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization, J. Neural Transm. Gen. Sect., 91 (1993) 13-25.
34. Nakajima, T., Daval, J.L., Morgan, P.P., Post, R.M. and Marangos, P.J., Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain, Brain Res., 501 (1989) 307-314.
35. Nehlig, A., Daval, J.L. and Debry, G., Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev., 17 (1992) 139-170.
36. Nikodijevic, O., Jacobson, K.A. and Daly, J.W., Locomotor activity in mice during chronic treatment with caffeine and withdrawal Pharmacol. Biochem. Behav., 44 (1993) 199-216 [published erratum appears in Pharmacol. Biochem. Behav., 45 (1993) 1003].
37. Ohno, M., Yoshida, H. and Watanabe, S., NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioural sensitization, Brain Res., 665 (1994) 136-140.
38. 3H]-CGS 21680 as a ligand, Naunyn-Schmiedeberg's Arch. Pharmacol., 342 (1990) 85-89.
39. Pelto-Huikko, M., Dagerlind, Å., Ceccatelli, S. and Hökfelt, T., The immediate-early genes c-fos and c-jun are differentially expressed in the rat adrenal gland after capsaicin treatment, Neurosci. Lett., 126 (1991) 163-166.
40. Porter, R.H.P. and Greenamyre, J.T., Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential, J. Neurochem., 64 (1995) 614-623.
41. Robertson, D., Wade, D., Workman, R., Woosley, R.L. and Oates, J.A., Tolerance to the humoral and hemodynamic effects of caffeine in man, J. Clin. Invest., 67 (1981) 1111-1117.
42. Robertson, G.S., Tetzlaff, W., Bedard, A., St-Jean, M. and Wigle, N., c-fos mediates antipsychotic-induced neurotensin gene expression in rodent striatum, Neuroscience, 67 (1995) 325-344.
43. 1) receptor by caffeine treatment, Neurosci. Lett., 103 (1989) 275-280.
44. Sheng, M. and Greenberg, M.E., The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron, 4 (1990) 477-485.
45. Stoner, G.R., Skirboll, L.R., Werkman, S. and Hommer, D.W., Preferential effects of caffeine on limbic and cortical dopamine systems, Biol. Psychiatry, 23 (1988) 761-768.
46. Svenningsson, P., Johansson, B. and Fredholm, B.B., Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum, Acta Physiol. Scand., 154 (1995) 17-24.
47. Svenningsson, P., Nomikos, G.G. and Fredholm, B.B., Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration, J. Neurosci., (1995) in press.
48. Svenningsson, P., Ström, A., Johansson, B. and Fredholm, B.B., Increased expression of c-jun, junB, AP-1 and preproenkephalin mRNA in rat striatum following a single injection of caffeine, J. Neurosci., 15 (1995) 3583-3593.
49. Svensson, A., Pileblad, E. and Carlsson, M., A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CCPene with regard to dopamine turnover and locomotor-stimulatory properties in mice, J. Neural Transm. Gen. Sect., 85 (1991) 117-129.
50. Torres, G. and Rivier, C., Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists, Brain Res. Bull., 30 (1993) 173-176.
51. Wisden, W., Errington, M.L., Williams, S., Dunnitt, S.B., Waters, C., Hitchcock, D., Evan, G., Bliss, T.V.P. and Hunt, S.P., Differential expression of immediate early genes in the hippocampus and spinal cord, Neuron, 4 (1990) 603-614.
52. Wolf, M.E., White, F.J. and Hu, X.-T., MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine, J. Neurosci., 14 (1994) 1735-1745.
53. Zukin, R.S. and Bennett, M.V.L., Alternatively spliced isoforms of the NMDARI receptor subunit, Trends Neurosci., 18 (1995) 306-313.